Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440031 (US10633389, Example 368-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440032 (US10633389, Example 369-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440033 (US10633389, Example 370-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440073 (US10633389, Example 412-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440089 (US10633389, Example 429-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440095 (US10633389, Example 435-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440102 (US10633389, Example 442-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440107 (US10633389, Example 448-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440127 (US10633389, Example 468-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440154 (US10633389, Example 503-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440155 (US10633389, Example 504-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440167 (US10633389, Example 516-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440182 (US10633389, Example 531-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440192 (US10633389, Example 541-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440200 (US10633389, Example 549-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440220 (US10633389, Example 570-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440272 (US10633389, Example 622-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440330 (US10633389, Example 682-1a) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440359 (US10633389, Example 24-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440363 (US10633389, Example 28-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440364 (US10633389, Example 29-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440381 (US10633389, Example 46-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440383 (US10633389, Example 48-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440390 (US10633389, Example 55-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440391 (US10633389, Example 56-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440395 (US10633389, Example 60-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440396 (US10633389, Example 61-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440399 (US10633389, Example 64-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440400 (US10633389, Example 65-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440402 (US10633389, Example 67-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440404 (US10633389, Example 69-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440410 (US10633389, Example 75-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440440 (US10633389, Example 105-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440455 (US10633389, Example 120-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440463 (US10633389, Example 128-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440469 (US10633389, Example 134-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440472 (US10633389, Example 138-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440478 (US10633389, Example 144-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440483 (US10633389, Example 149-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440490 (US10633389, Example 156-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440492 (US10633389, Example 158-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440515 (US10633389, Example 181-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440523 (US10633389, Example 189-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440529 (US10633389, Example 195-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440540 (US10633389, Example 206-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440546 (US10633389, Example 212-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440568 (US10633389, Example 234-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440570 (US10633389, Example 236-3 | US10633389, Example 23...) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440577 (US10633389, Example 243-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-arginine methyltransferase CARM1 (Homo sapiens (Human)) | BDBM440580 (US10633389, Example 246-3) | PDB Reactome pathway UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | UniChem | US Patent | n/a | n/a | <100 | n/a | n/a | n/a | n/a | n/a | n/a |
Epizyme, Inc. US Patent | Assay Description The assays were all performed in a buffer consisting of 20 mM Bicine (pH=7.6), 1 mM TCEP, 0.005% BSG, and 0.002% Tween 20, prepared on the day of use... | US Patent US10633389 (2020) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Displayed 1 to 50 (of 1029 total ) | Next | Last >> |
